|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Creemers EE, Tijsen AJ and Pinto YM:
Circulating MicroRNAs: Novel biomarkers and extracellular
communicators in cardiovascular disease? Circ Res. 110:483–495.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Munker R and Calin GA: MicroRNA profiling
in cancer. Clin Sci (Lond). 121:141–158. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jiang C, Chen X, Alattar M, Wei J and Liu
H: MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis
of gastric cancer. Cancer Gene Ther. 22:291–301. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shrestha S, Hsu SD, Huang WY, Huang HY,
Chen W, Weng SL and Huang HD: A systematic review of microRNA
expression profiling studies in human gastric cancer. Cancer Med.
3:878–888. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ueda T, Volinia S, Okumura H, Shimizu M,
Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: A microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang R, Wen H, Xu Y, Chen Q, Luo Y, Lin Y,
Luo Y and Xu A: Circulating microRNAs as a novel class of
diagnostic biomarkers in gastrointestinal tumors detection: A
meta-analysis based on 42 articles. PLoS One. 9:e1134012014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li B, Zhao Y, Guo G, Li W, Zhu ED, Luo X,
Mao XH, Zou QM, Yu PW, Zuo QF, et al: Plasma microRNAs, miR-223,
miR-21 and miR-218, as novel potential biomarkers for gastric
cancer detection. PLoS One. 7:e416292012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gorur A, Fidanci Balci S, Dogruer Unal N,
Ayaz L, Akbayir S, Yildirim Yaroglu H, Dirlik M, Serin MS and Tamer
L: Determination of plasma microRNA for early detection of gastric
cancer. Mol Biol Rep. 40:2091–2096. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Song MY, Pan KF, Su HJ, Zhang L, Ma JL, Li
JY, Yuasa Y, Kang D, Kim YS and You WC: Identification of serum
microRNAs as novel non-invasive biomarkers for early detection of
gastric cancer. PLoS One. 7:e336082012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Qiu X, Zhang J, Shi W, Liu S, Kang M, Chu
H, Wu D, Tong N, Gong W, Tao G, et al: Circulating MicroRNA-26a in
plasma and its potential diagnostic value in gastric cancer. PLoS
One. 11:e01513452016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu X, Lv M, Wang H and Guan W:
Identification of circulating MicroRNAs as novel potential
biomarkers for gastric cancer detection: A systematic review and
meta-analysis. Dig Dis Sci. 59:911–919. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mestdagh P, Van Vlierberghe P, De Weer A,
Muth D, Westermann F, Speleman F and Vandesompele J: A novel and
universal method for microRNA RT-qPCR data normalization. Genome
Biol. 10:R642009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Peltier HJ and Latham GJ: Normalization of
microRNA expression levels in quantitative RT-PCR assays:
Identification of suitable reference RNA targets in normal and
cancerous human solid tissues. RNA. 14:844–852. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sperveslage J, Hoffmeister M, Henopp T,
Klöppel G and Sipos B: Establishment of robust controls for the
normalization of miRNA expression in neuroendocrine tumors of the
ileum and pancreas. Endocrine. 46:226–230. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Juzėnas S, Saltenienė V, Kupcinskas J,
Link A, Kiudelis G, Jonaitis L, Jarmalaite S, Kupcinskas L,
Malfertheiner P and Skieceviciene J: Analysis of deregulated
microRNAs and their target genes in gastric cancer. PLoS One.
10:e01323272015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Benz F, Roderburg C, Cardenas Vargas D,
Vucur M, Gautheron J, Koch A, Zimmermann H, Janssen J,
Nieuwenhuijsen L, Luedde M, et al: U6 is unsuitable for
normalization of serum miRNA levels in patients with sepsis or
liver fibrosis. Exp Mol Med. 45:e422013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zheng G, Wang H, Zhang X, Yang Y, Wang L,
Du L, Li W, Li J, Qu A, Liu Y and Wang C: Identification and
validation of reference genes for qPCR detection of serum microRNAs
in colorectal adenocarcinoma patients. PLoS One. 8:e830252013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
van Beers EH, Joosse SA, Ligtenberg MJ,
Fles R, Hogervorst FB, Verhoef S and Nederlof PM: A multiplex PCR
predictor for aCGH success of FFPE samples. Br J Cancer.
94:333–337. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Andersen CL, Jensen JL and Ørntoft TF:
Normalization of real-time quantitative reverse transcription-PCR
data: A model-based variance estimation approach to identify genes
suited for normalization, applied to bladder and colon cancer data
sets. Cancer Res. 64:5245–5250. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vlachos IS, Zagganas K, Paraskevopoulou
MD, Georgakilas G, Karagkouni D, Vergoulis T, Dalamagas T and
Hatzigeorgiou AG: DIANA-miRPath v3.0: Deciphering microRNA function
with experimental support. Nucleic Acids Res. 43:W460–W466. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pritchard CC, Cheng HH and Tewari M:
MicroRNA profiling: Approaches and considerations. Nat Rev Genet.
13:358–369. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang XW, Wu Y, Wang D and Qin ZF: MicroRNA
network analysis identifies key microRNAs and genes associated with
precancerous lesions of gastric cancer. Genet Mol Res.
13:8695–8703. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wong CM, Wei L, Au SL, Fan DN, Zhou Y,
Tsang FH, Law CT, Lee JM, He X, Shi J, et al: MiR-200b/200c/429
subfamily negatively regulates Rho/ROCK signaling pathway to
suppress hepatocellular carcinoma metastasis. Oncotarget.
6:13658–13670. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hur K, Toiyama Y, Takahashi M, Balaguer F,
Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR and Goel A:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hill L, Browne G and Tulchinsky E:
ZEB/miR-200 feedback loop: At the crossroads of signal transduction
in cancer. Int J Cancer. 132:745–754. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li H, Xu L, Li C, Zhao L, Ma Y, Zheng H,
Li Z, Zhang Y, Wang R, Liu Y and Qu X: Ubiquitin ligase Cbl-b
represses IGF-I-induced epithelial mesenchymal transition via ZEB2
and microRNA-200c regulation in gastric cancer cells. Mol Cancer.
13:1362014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tang H, Deng M, Tang Y and Xie X, Guo J,
Kong Y, Ye F, Su Q and Xie X: MiR-200b and miR-200c as prognostic
factors and mediators of gastric cancer cell progression. Clin
Cancer Res. 19:5602–5612. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang HP, Sun FB and Li SJ: Serum miR-200c
expression level as a prognostic biomarker for gastric cancer.
Genet Mol Res. 14:15913–15920. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gao J and Liu QG: The role of miR-26 in
tumors and normal tissues (Review). Oncol Lett. 2:1019–1023.
2011.PubMed/NCBI
|
|
35
|
Kato M, Goto Y, Matsushita R, Kurozumi A,
Fukumoto I, Nishikawa R, Sakamoto S, Enokida H, Nakagawa M,
Ichikawa T and Seki N: MicroRNA-26a/b directly regulate La-related
protein 1 and inhibit cancer cell invasion in prostate cancer. Int
J Oncol. 47:710–718. 2015.PubMed/NCBI
|
|
36
|
Ramachandran K, Saikumar J, Bijol V,
Koyner JL, Qian J, Betensky RA, Waikar SS and Vaidya VS: Human
miRNome profiling identifies MicroRNAs differentially present in
the urine after kidney injury. Clin Chem. 59:1742–1752. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen J, Zhang K, Xu Y, Gao Y, Li C, Wang R
and Chen L: The role of microRNA-26a in human cancer progression
and clinical application. Tumor Biol. 37:7095–7108. 2016.
View Article : Google Scholar
|
|
38
|
Li H, Sun Q, Han B, Yu X, Hu B and Hu S:
MiR-26b inhibits hepatocellular carcinoma cell proliferation,
migration, and invasion by targeting EphA2. Int J Clin Exp Pathol.
8:4782–4790. 2015.PubMed/NCBI
|
|
39
|
Zheng WD, Zhou FL and Lin N: MicroRNA-26b
inhibits osteosarcoma cell migration and invasion by
down-regulating PFKFB3 expression. Genet Mol Res. 14:16872–16879.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lin J, Zhang L, Huang H, Huang Y, Huang L,
Wang J, Huang S, He L, Zhou Y, Jia W, et al: MiR-26b/KPNA2 axis
inhibits epithelial ovarian carcinoma proliferation and metastasis
through downregulating OCT4. Oncotarget. 6:23793–23806. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xia M, Duan ML, Tong JH and Xu JG: MiR-26b
suppresses tumor cell proliferation, migration and invasion by
directly targeting COX-2 in lung cancer. Eur Rev Med Pharmacol Sci.
19:4728–4737. 2015.PubMed/NCBI
|
|
42
|
Xie J, Chen M, Zhou J, Mo MS, Zhu LH, Liu
YP, Gui QJ, Zhang L and Li GQ: miR-7 inhibits the invasion and
metastasis of gastric cancer cells by suppressing epidermal growth
factor receptor expression. Oncol Rep. 31:1715–1722.
2014.PubMed/NCBI
|
|
43
|
Inoue T, Iinuma H, Ogawa E, Inaba T and
Fukushima R: Clinicopathological and prognostic significance of
microRNA-107 and its relationship to DICER1 mRNA expression in
gastric cancer. Oncol Rep. 27:1759–1764. 2012.PubMed/NCBI
|
|
44
|
Cooney CA, Jousheghany F, Yao-Borengasser
A, Phanavanh B, Gomes T, Kieber-Emmons AM, Siegel ER, Suva LJ,
Ferrone S, Kieber-Emmons T and Monzavi-Karbassi B: Chondroitin
sulfates play a major role in breast cancer metastasis: A role for
CSPG4 and CHST11 gene expression in forming surface P-selectin
ligands in aggressive breast cancer cells. Breast Cancer Res.
13:R582011. View Article : Google Scholar : PubMed/NCBI
|
